A Phase 3, Multicentre, Open Label Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

Moore, Gregory (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

NMA HREC Reference Number: HREC/18/SVHM/58 (ERM Project ID: 39890)
NMA SSA Reference Number: SSA/18/MonH/565
Monash Health Ref: RES-18-0000-443X

Status	Finished
Effective start/end date	7/11/19 → 6/11/24

Keywords

clinical trial
phase 3 study
treatment efficacy
Crohn's Disease